ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Acadia Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia americanpharmaceuticalreview
April 09, 2021Acadia Pharmaceuticals Inc. announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for NUPLAZID? (pimavanserin) for the treatment ... -
Benzodiazepines With Opioid Agonist Tx May Up Mortality Risk drugs
December 18, 2019Coprescription of benzodiazepines and opioid agonist treatment (OAT) is associated with an increased risk for drug-related poisoning (DRP) mortality in opioid-dependent individuals ...
Pharma Sources Insight January 2025
